Abstract:Background: Breast cancer is the leading cause of cancer death in women. The current methods of chemotherapy for breast cancer generally have strong adverse reactions and drug resistance. Therefore, the discovery of novel anti-breast cancer lead compounds is urgently needed. Objective: This study aimed to design and synthesize a series of 2-alkyl substituted fluorinated genistein analogues and evaluate their anti-breast cancer activity. Methods: Target compounds were obtained in a multistep reaction synthesis. The anti-tumor activity of compounds I-1~I-35 was evaluated with MCF-7, MDA-MB-231, MDA-MB-435, and MCF-10A cell lines in vitro, with tamoxifen as the positive control. Molecular docking was used to study the interaction between the synthesized compounds and PI3K-gamma. Results: A series of 2-alkyl substituted fluorinated genistein analogues was designed, synthesized, and screened for their bioactivity. Most of the compounds displayed better selectivity toward breast cancer cell lines as compared to tamoxifen. Among these analogues, I-2, I-3, I-4, I-9, I-15, and I-17 have the strongest selective inhibition of breast cancer cells. Compounds I-10, I-13, I-15, I-17, and I- 33 were found to have significant inhibitory effects on breast cancer cells. Molecular docking studies have shown that these compounds may act as PI3Kγ inhibitors and may further exhibit anti-breast cancer effects. Conclusion: Most of the newly synthesized compounds could highly, selectively inhibit breast cancer cell lines. The experimental results indicate that the synthesized analogs may also have obvious selective inhibitory effects on other malignant proliferation cancer cells.

Synthesis and Cytotoxicity Evaluation of 3-Amino-2-hydroxypropoxygenistein Derivatives.

Synthesis and Cytotoxicity Evaluation of 3-Amino-2-hydroxypropoxyisoflavone Derivatives.

The Mechanisms Of Anticancer Agents By Genistein And Synthetic Derivatives Of Isoflavone

Synthesis And Cytotoxic Evaluation Of A Series Of Genistein Derivatives

Synthesis of Flavone Derivatives via N-Amination and Evaluation of Their Anticancer Activities

Synthesis and Characterization of a Series of Genistein Derivatives As Selective Estrogen Receptor Modulators

Synthesis and Bio-evaluation of 2-Alkyl Substituted Fluorinated Genistein Analogues Against Breast Cancer.

Synthesis And Biological Evaluation Of 3-Aryl-Quinoxaline-2-Carbonitrile 1,4-Di-N-Oxide Derivatives As Hypoxic Selective Anti-Tumor Agents

Synthesis And Evaluation Of New Podophyllotoxin Derivatives With In Vitro Anticancer Activity

Synthesis of Novel 3-(Substituted Phenyl) Chromone Derivatives and Their Anti-Tumor Activities

Genistein and Its Synthetic Analogs As Anticancer Agents

Synthesis and Cytotoxic Evaluation of Novel 7‐o‐modified Genistein Derivatives

Synthesis and Antitumor Activities of Novel 3-(Substituted Phenyl) Chromone Derivatives

Synthesis, Pharmacological Activity of a Series of Genistein Derivatives as Modulators of Multidrug Resistance

Synthesis, characterization and in vitro antiproliferative effects of isosteviol derivatives

Synthesis and Anti-Proliferative Activities of 5,6,7-Trimethoxyflavones and Their Derivatives

Synthesis and biological evaluation of novel Jiyuan Oridonin A-1,2,3-triazole-azole derivatives as antiproliferative agents.

Discovery of oxime-bearing naphthalene derivatives as a novel structural type of Nrf2 activators

Synthesis and Biological Evaluation of 7-O-modified Oroxylin A Derivatives.

Synthesis and Biological Evaluation of a Natural Ester Sintenin and Its Synthetic Analogues

Synthesis and in vitro and in vivo biological evaluation of novel derivatives of flexicaulin A as antiproliferative agents